Orthogem Ltd is a biomaterials company who have developed a new generation of synthetic bone graft substitute. The platform technology called Tripore consists of granules of hydroxyapatite (material which makes up natural bone) containing pores in a range of three sizes, meaning it is uniquely fully resorbable i.e. replaced by natural bone. The product and production process are patent protected, extending worldwide, allowing the company to develop a range of product extensions for use in a variety of clinical scenarios.

Status current

Associated Fund Early Advantage Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

Valuable Funding for Biomaterials Company

8 April 2011 A company whose synthetic bone-graft implants demonstrate world-beating performance will complete regulatory…

read more

Oxford Technology 3 Venture Capital Trust Plc : Half-year report

During the period, with the exception of Ixaris and Orthogem as mentioned above, the...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now